Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003)
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/28/1/116/10296938/mdw439.pdf
Reference22 articles.
1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009
2. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer;Kelsen;N Engl J Med,1998
3. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012
4. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer;Allum;J Clin Oncol,2009
5. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907);Ando;Ann Surg Oncol,2012
Cited by 98 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical Impact of Conversion Surgery After Induction Therapy for Esophageal Cancer with Synchronous Distant Metastasis: A Multi-institutional Retrospective Study;Annals of Surgical Oncology;2024-02-01
2. Neoadjuvant Chemotherapy or Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma;Annals of Surgical Oncology;2023-11-14
3. Indications for neoadjuvant chemotherapy in older patients undergoing esophagectomy for esophageal cancer;Surgery Today;2023-10-31
4. Skeletal Muscle Quality and Quantity Affect Prognosis after Neoadjuvant Chemotherapy with a Triple Regimen of Docetaxel/Cisplatin/5-FU in Patients with Esophageal Cancer;Journal of Clinical Medicine;2023-10-25
5. Association between circ_0004365 and cisplatin resistance in esophageal squamous cell carcinoma;Oncology Letters;2023-09-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3